Moderna (MRNA) surged about 177% after it and Merck (MRK) reported the first positive Phase 3 result for an mRNA cancer ...
Moderna just transformed from a cash-burning vaccine maker into a serious acquirer, and four biotech targets are already ...
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are rocketing higher Wednesday morning, with the stock up 93% to $121 ...
Investor's Business Daily on MSN
Moderna and Merck's cancer vaccine: Are investors putting the cart before the horse?
Moderna and Merck scored a big win for their cancer vaccine on Wednesday. But analysts say it's too early to call it a home ...
Moderna announced an update on their ongoing clinical study. Claim 55% Off TipRanks. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investme ...
Dr. Anthony Fauci greenlit a COVID-19 vaccination study on pregnant women to “fill gaps in our knowledge” after he privately theorized that the injection could possibly cause miscarriages in the first ...
Lilly ( LLY) raised its full-year guidance, implying $85.0B - $87.0B in revenue, which fell short of $85.4B in the consensus at the midpoint. Its adjusted EPS outlook of $35.50 - $36.50 exceeded ...
Two Senate Republicans released a set of 2021 texts that show Dr. Anthony Fauci discussing how to "weigh the potential risks ...
Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 ...
12d
Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update
The intervention is a single intramuscular dose of the BNT162b2 2025/2026 formulation, a biological vaccine tailored to the SARS‑CoV‑2 strain expected to dominate the 2025–2026 season. It is designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results